Citigroup Inc Gt Biopharma, Inc. Transaction History

Citigroup Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$1.64 - $3.11 $762 - $1,446	-465 Reduced 72.77%	174 $1,000
Q1 2022 May 12, 2022	SELL	$2.6 - $3.3 $10,225 - $12,978	-3,933 Reduced 86.02%	639 $2,000
Q4 2021 Feb 10, 2022	BUY	$3.05 - $7.08 $7,658 - $17,777	2,511 Added 121.83%	4,572 $14,000
Q3 2021 Nov 10, 2021	BUY	$6.68 - $15.26 $13,767 - $31,450	2,061 New	2,061 $14,000

564

Ticker GTBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,557,700
Market Cap $96.4M
Description
GT Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology products based on its proprietary Tri-specific Killer Engager (TriKE) fusion protein immune cell engager technology platform. It develops GTB-3550, a single-chain tri-specific recombinant fusion protein conjugate th...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.